Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Advaxis, Inc.
Duke University
Kaiser Permanente
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
Novartis
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company